FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to ophthalmology. The ophthalmic preparations are used in ophthalmic diseases as a lacrimal substitute, and they contain a combination of hyaluronic acid and a polysaccharide known as TSP (a Tamarindus indica seed polysaccharide). The ophthalmic preparations suggested to be used in treating a dry eye syndrome contain in a combination of 0.05 to 2 wt % of the tamarind seed polysaccharide and 0.05 to 1 wt % of hyaluronic acid in the aqueous solution.
EFFECT: when administered in a combination of hyaluronic acid and TSP, the invention provides a synergistic effect in stimulating the normal conjunctival mucosa recovery if affected by the dry eye syndrome, thereby inducing a noticeable improvement of the number and morphology of the conjunctival microvilli.
16 cl, 9 tbl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITIONS CONTAINING MUCOADHESIVE POLYSACCHARIDES STIMULATING CORNEAL EPITHELIUM RECOVERY | 2006 |
|
RU2493854C2 |
| OPHTHALMIC COMPOSITIONS CONTAINING MUCOADHESIVE POLYSACCHARIDES ABLE TO PROMOTE CORNEAL RE-EPITHELISATION | 2013 |
|
RU2663449C2 |
| COMPOSITIONS PROVIDING INCREASED COMFORT FOR THE EYES | 2018 |
|
RU2806029C2 |
| PYRROLIDONE-CARBOXYLIC ACID (PCA) FOR OPHTHALMIC USE | 2016 |
|
RU2720993C2 |
| PHARMACEUTICAL FORMULATIONS OF NON-POLAR AND POLAR LIPIDS FOR OPHTHALMOLOGICAL APPLICATION | 2007 |
|
RU2495661C2 |
| GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
| OPHTHALMIC MOISTURIZING SOLUTION | 2019 |
|
RU2706703C1 |
| SOLUBLE POLYMER EYE INSERTS AND THEIR APPLICATION METHOD | 2020 |
|
RU2791026C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT FOR PREVENTING OR TREATING DRY EYES SYNDROME | 2018 |
|
RU2722485C1 |
| EYE DROPS | 2010 |
|
RU2431470C1 |
